Rheumatology Network's Top 5: December 3, 2021
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending December 3, 2021.
Louis Bessette, MD, MSc: Pain Improvement and Patient-Reported Outcomes in Patients with Psoriatic Arthritis
Louis Bessette, MD, MSc, explains the impact of early pain improvement on patient-reported outcomes in patients with psoriatic arthritis.
Click the image to view the story.
Philip Mease, MD: Guselkumab Achieves Long-term Improvements in Psoriatic Arthritis Symptoms
Philip Mease, MD, explains the recent Phase 3 data from the DISCOVER-1 and DISCOVER-2 clinical trials which demonstrated guselkumab inhibited radiographic progression, and improved symptoms and pain in patients with active psoriatic arthritis (PsA).
Click the image to view the story.
Paul R. Fortin, MD, MPH, FRCPC: COVID-19 Vaccine for Patients With Rheumatic Disease
Paul R. Fortin, MD, MPH, FRCPC, discusses the impact of the COVID-19 vaccine in immunosuppressed adults and those with autoimmune diseases.
Click the image to view the story.
Stuart Kassan, MD: Encouraging Self-Advocacy in Newly Diagnosed Patients
Stuart Kassan, MD, discusses Rheumatology Research Foundation's recent patient webinar, "Just Diagnosed: Now What?”
Click the image to view the story.
Benjamin Terrier, MD, PhD: Rituximab for Eosinophilic Granulomatosis with Polyangiitis
Benjamin Terrier, MD, PhD, discusses his study and ACR presentation, “Rituximab versus Conventional Therapeutic Strategy for Remission Induction in Eosinophilic Granulomatosis with Polyangiitis: A Double-blind, Randomized, Controlled Trial.”
Click the image to view the story.
